WDM(600055) Zheng Quan Zhi Xing·2025-05-30 09:32Core Viewpoint - Beijing Wandong Medical Technology Co., Ltd. has completed the registration of its 2025 stock option incentive plan, granting a total of 9.6 million stock options to 85 individuals, with the registration completed on May 30, 2025 [1][2][9] Group 1: Stock Option Plan Details - The stock option plan has a maximum validity period of 60 months from the date of the first grant [5] - The waiting periods for the stock options are set at 12, 24, and 36 months, with specific percentages of options available for exercise at each stage [5][6] - The performance assessment for the stock options will be based on the company's revenue growth and R&D investment rates over the fiscal years 2025 to 2027 [6][7] Group 2: Performance Assessment Criteria - The performance targets for the first, second, and third exercise periods are linked to the company's revenue, with specific thresholds set at 85% of the previous year's revenue [7][8] - Individual performance assessments will also influence the exercise of stock options, categorized into five levels (S, A, B, C, D) [8] Group 3: Financial Impact - The company will use the Black-Scholes model to calculate the fair value of the stock options, and adjustments will be made based on the number of options expected to be exercised and performance metrics [9]